The rise of ‘tweakment tourism' to South Korea
Beauty isn't so much an industry in South Korea as a way of life. 'There's a mantra there that within a beautiful body rests a beautiful soul,' says Dr Christine Hall, a British-Korean GP who practises aesthetic medicine at the Taktouk Clinic in Knightsbridge. The importance of presenting the best version of yourself is ingrained from young, she explains, and considered a sign of respect for others. 'There are good and bad sides to this — there's a lot of pressure to look good.' It has ultimately led South Korea to be a world leader not only in products but also in treatments: Seoul has more plastic surgeons per capita than anywhere else on the planet. 'It's estimated that South Korea is about 10 to 12 years ahead of us when it comes to beauty innovations. As an example, PDRN [the buzzed-about salmon DNA treatment that has taken off in the UK] arrived in South Korea in 2014. In fact, it was first formulated into a cosmetic injectable there.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
8 hours ago
- Daily Mail
Experts warn of another global epidemic as rare virus spreads to new areas
The World Health Organization has issued an urgent call for action as cases of chikungunya virus explode across the globe. The chikungunya virus is spread primarily by the Aedes mosquito species and nearly half a million people became infected between 2004 and 2005 - leading to a worldwide epidemic. Chikungunya infections are most common in Asia, Africa and South America though more recently cases have also emerged across Europe and the US. The virus can cause symptoms like fever, joint pain and life-threatening complications related to the heart and brain. The infection does not spread from person to person through bodily contact or saliva and can only be transmitted through a bite from an infected mosquito. Since there is no specific medical treatment for the chikungunya infections, experts are asking people to regularly use insect repellents and wear long-sleeve clothing to prevent mosquito bites this summer Diana Rojas Alvarez, a medical officer at the who said of the new cases: 'We are seeing history repeating itself,' referencing the 2004-2005 epidemic. The current surge began in early 2025, with major outbreaks in the Indian Ocean islands of La Reunion, Mayotte and Mauritius. According to the European Center for Disease Prevention and Control, there have been about 220,000 Chikungunya virus cases and 80 related deaths in 14 countries since the beginning of 2025. An estimated one-third of La Reunion's population - nearly 300,000 people - have already been infected, according to Rojas Alvarez. During the last epidemic, about 266,000 people were infected out of which 203 died on La Reunion. The virus has also spread to Madagascar, Somalia, Kenya and India and is making its way to Europe. There have been approximately 800 imported chikungunya cases in continental France since May 1, Rojas Alvarez said. Out of the 800 cases, 12 of the infected people had been bitten by local mosquitoes without having travelled to high-risk areas in several southern French regions. The chikungunya outbreak has occurred far earlier in the year than is typical, and this could indicate the mosquitoes that carry chikungunya are becoming increasingly at home in France thanks to climate change, officials warned. Two cases have also been reported in Italy this week and both people were infected within the country rather than abroad, according to the Foreign Office-backed Travel Health Pro. In June of this year, Australian vacationers were issued a warning AS The Cook Islands, a nation in the South Pacific, declared the most recent outbreak of the disease after 19 cases were recorded. Case counts have also been increasing in Samoa, Tonga, French Polynesia, Fiji and Kiribati. As of July 16, two dozen cases of chikungunya infections in the US that had been contracted while traveling to high-risk areas have been reported by the CDC. While it remains unclear where patients contracted the virus, the federal agency has issued an elevated risk of exposure notice for Brazil, Colombia, India, Mexico, Nigeria, Pakistan, Philippines and Thailand. Approximately 200 cases of the virus were reported in 2024 in the US. According to the CDC, chikungunya was rarely identified in American travelers before 2006. However between 2006– and 2013, nearly 30 people tested positive for the infection every year in the US. All were travelers visiting or returning to the US from affected areas in Asia, Africa, or the Indian Ocean. In 2014, 2,799 cases, out of which 12 were locally-acquired, were reported in various US states including Florida, Texas, Puerto Rico, and the Virgin Islands - marking the year as the highest ever. Though not fatal, chikungunya can cause a range of effects, which are primarily marked by a sudden onset of fever and severe joint pain, while other common symptoms include muscle pain, headache, nausea, fatigue and rashes. While the acute phase of the illness usually resolves within a week or two, the joint pain can persist for weeks, months or even years in some individuals. However, in some cases, infections can progress to severe dengue, which can cause potentially life-threatening complications such as internal bleeding and organ damage, and death. In extreme cases, eye, heart and neurological complications have also been reported in people suffering from a chikungunya infection. Newborns, adults aged 65 and older and people with certain health conditions are also at the risk of developing Type 2 diabetes, heart disease and high blood pressure due to an infection. While the virus cannot be transmitted directly from person to person, people can become infected with chikungunya when mosquitoes feed on another infected person and then bite them. If a pregnant woman is infected around the time of delivery, the baby can also be infected at birth, which often results in severe disease in the baby. While there is no medication to treat a chikungunya infection, its symptoms can be managed by taking acetaminophen for pain and drinking lots of fluids. In late 2023, the FDA also approved a vaccine for chikungunya for people over the age of 18 who are at increased risk of exposure to the virus called IXCHIQ.
The Independent
12 hours ago
- The Independent
Scientists create temporary tattoo that detects if your drink has been spiked
Scientists have created a temporary tattoo that can detect if a drink has been spiked with just a couple drops. The sticker, which is applied to the skin, can detect the presence of the drug Y-hydroxybutyrate (GHB) even in low concentrations within one second. Commonly used to spike drinks, the central nervous system depressant drug Rohypnol, known as roofies or GHB, has been liked with sexual assault. It causes drowsiness, slows down your breathing and reduces heart rate. These drugs are colourless, tasteless and induce a stupor in victims that is similar to severe alcohol intoxication – leaving people vulnerable to sexual assault. The prevalence of spiking is high with 11 per cent of UK adults report being spiked at any point in their lives, according to Drinkaware. It added that 9 per cent of men and 13 per cent of women have reported their drink being spiked. There are ways people can protect themselves from drink spiking, with specialised strips and cards that change colour when exposed to these drugs. But many of these drug testing kits are conspicuous or take minutes to report a result. In the study published in the journal ACS Sensors, researchers in South Korea set out to develop a rapid-acting test for GHB that's worn on the skin using a tattoo-like sticker. Gyeong-Ji Kim, Jai Eun An, Kyong-Cheol Ko, Oh Seok Kwon and colleagues created the stickers by placing a mould over the top of a thin plastic film decorated with tattoo-like designs. They poured a gel mixture into the mould which contained a chemical receptor that turns red when it detects GHB. The back of the sticker was then coated with a diluted glue solution, so it could stick to skin. Researchers tested the sticker's ability to detect small amounts of GHB in a variety of beverages: whiskey, vodka, beer, soju (a Korean alcoholic beverage) and coffee. The drug was detected within one second of coming into contact with the contaminated drinks. It even changed colour when it detected levels of the drug lower than what would induce serious physiological symptoms – 0.01 micrograms of GHB in 1 millilitre of beverage. The sticker is designed to be able to discreetly dip a finger into a drink, touch the drop to the sticker and see the result almost immediately. A positive result displays for up to 30 days after detection, which could be important if it's needed as a form of evidence of tampering. The researchers say that their sticker technology is inexpensive and easy to manufacture, and it could be commercially available soon.
Daily Mail
14 hours ago
- Daily Mail
Scientists develop a temporary tattoo that detects date rape drugs in drinks within 1 SECOND
It's something that has happened to around one in 10 women and one in 20 men. But detecting if your drink has been spiked could soon be as simple as dabbing some of it onto your arm. Scientists from the Korea Research Institute of Bioscience and Biotechnology have developed a temporary tattoo that can detect the presence of 'date rape' drugs. If the tattoo detects even low concentrations of y–hydroxybutyrate (GHB), it will change from yellow to red. Best of all, this process is almost instantaneous – taking around one second, according to the researchers. There are already a range of measures available for drinkers to limit access to their drinks, including anti–spiking drink covers and films. However, the researchers hope the new tattoo will offer a quick and simple way to ensure beverages are safe. 'This innovation represents a proactive and accessible solution for preventing DFSAs –[drug–related sexual assault], enhancing personal safety, and fostering a sense of control and awareness in high–risk environments,' the team explained. Spiking occurs when someone puts drugs into another person's drink without their knowledge or consent – often to make it easier to rape or sexually assault them. 'Spiking can happen for different reasons – for example, because someone thinks it's funny or because someone wants to commit a crime against the person they're spiking, such as theft, rape or sexual assault,' Rape Crisis explains on its website. 'Whatever the motive, spiking is never okay or funny. 'It can make a person extremely vulnerable and ill, and have a lasting impact on their wellbeing and life.' One of the most common date rape drugs is GHB, which can cause dizziness, confusion, short–term amnesia, and even unconsciousness. Unfortunately, detecting if your drink has been spiked can prove tricky. Writing in their study, published in ACS Sensors, the team, led by Kim Gyeong–Ji, explained: 'The drug used for date rape is odorless, colorless, and tasteless, which can be completely dissolved in beverages to avoid suspicion.' There are already several GHB detection measures available, including specialised strips or cards that change colour when exposed to the drug. To create the tattoo stickers, the researchers placed a mold over the top of a thin plastic film, decorated with tattoo–like designs However, most of these are time consuming, and aren't exactly subtle. In their new study, the team set out to develop a more accessible alternative – eventually settling on a temporary tattoo. To create the tattoo stickers, the researchers placed a mold over the top of a thin plastic film, decorated with tattoo–like designs. They then poured in a gel mixture containing a chemical receptor that turns red in the presence of GHB. Finally, they coated the back of the sticker with glue, so it could stick to the skin. To test the tattoo's accuracy, the team applied dabs of GHB dissolved in a variety of beverages, incuding whisky, vodka, beer, soju, and coffee. Across all beverages, the researchers found that the tattoo could detect the drug - even at low concentrations. 'In practice, a wearer could dip a finger into a beverage, touch the drop to the sticker and see the result almost immediately,' the researchers explained in a statement. What's more, the sticker displays the positive result for up to 30 days, which could be helpful if it's needed as evidence. Unfortunately, the price and timeline for availablity of the tattoo remain unclear at this stay. However, the researchers reassure that the sticker is 'inexpensive and easy to manufacture', and say it will be commercially available 'soon'.
